ArticleOpen forum infectious diseases2024

A Multicenter Assessment of the Outcomes and Toxicities of Foscarnet for Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex in Immunocompromised Patients.

Sarah P Hammond et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.